Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes

Thiazolidinedione, Rosiglitazone, Chemistry, Glucose homeostasis, Nuclear receptor, Peroxisome proliferator-activated receptor, Receptor, Diabetes mellitus, Pharmacology, Surface plasmon resonance, Internal medicine, Endocrinology, Type 2 diabetes, Biochemistry, Medicine, Insulin resistance, Transcription factor, Materials science, Nanotechnology